Ahead of Pfizer (PFE) Q1 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 04/30/26
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?The Motley Fool • 04/30/26
Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple MyelomaBusiness Wire • 04/29/26
Novo Nordisk vs. Pfizer: Which Healthcare Giant Is the Better Bet?Zacks Investment Research • 04/27/26
Want $1,188 in Passive Income? Invest $5,000 Into These 3 High-Yielding Stocks24/7 Wall Street • 04/27/26
Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacyReuters • 04/24/26
Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks24/7 Wall Street • 04/23/26
Just Five Dividend Stocks Transform $500,000 Into $3,100 a Month in Retirement Income24/7 Wall Street • 04/21/26
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026Business Wire • 04/21/26
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 DuopolyThe Motley Fool • 04/21/26
Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note saysReuters • 04/20/26
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin EligibilityPRNewsWire • 04/20/26